nach oben

Erschienen in:

01.06.2019 | Case report

Hydroxyzine

Sedation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a prospective, real-world, non-interventional, multicentric observational study involving 400 patients [CTRI/2017/06/008847], a 42-year-old woman¹ was described, who developed sedation during treatment with oral hydroxyzine [Atarax; hydroxyzine hydrochloride; dosage not stated] tablets for chronic pruritus. The therapy was scheduled for a duration of 12 weeks. The sedation resolved and no intervention was required [duration of treatment to reaction onset not stated]. …

Patient demographics obtained via author communication

Thomas J, et al. Real-World, Non-Interventional, Observational Study of Hydroxyzine Hydrochloride in Chronic Pruritus: a Prospective, Non-Comparative Study. Dermatology and Therapy 9: 299-308, No. 2, Jun 2019. Available from: URL: https://doi.org/10.1007/s13555-019-0293-2 - India

Titel: Hydroxyzine
Sedation: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64030-1

Springer Medizin

Hydroxyzine

Sedation: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Serious AEs linked with investigational faecal microbiota

Dexmedetomidine

Epirubicin/trastuzumab

Mitomycin

Anakinra

Morphine

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Serious AEs linked with investigational faecal microbiota

Dexmedetomidine

Epirubicin/trastuzumab

Mitomycin

Anakinra

Morphine